Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, Replimune Group Inc’s stock clocked out at $11.16, up 0.27% from its previous closing price of $11.13. In other words, the price has increased by $0.27 from its previous closing price. On the day, 0.51 million shares were traded. REPL stock price reached its highest trading level at $11.49 during the session, while it also had its lowest trading level at $11.04.
Ratios:
To gain a deeper understanding of REPL’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 13.46 and its Current Ratio is at 13.46. In the meantime, Its Debt-to-Equity ratio is 0.18 whereas as Long-Term Debt/Eq ratio is at 0.17.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, ROTH MKM on August 28, 2024, initiated with a Buy rating and assigned the stock a target price of $17.
On November 19, 2021, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $52.Piper Sandler initiated its Overweight rating on November 19, 2021, with a $52 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Aug 16 ’24 when Hill Emily Luisa sold 8,938 shares for $10.18 per share. The transaction valued at 90,989 led to the insider holds 101,057 shares of the business.
Xynos Konstantinos sold 15,881 shares of REPL for $119,108 on Jun 07 ’24. The Chief Medical Officer now owns 117,131 shares after completing the transaction at $7.50 per share. On May 16 ’24, another insider, Sarchi Christopher, who serves as the Chief Commercial Officer of the company, sold 2,218 shares for $6.47 each. As a result, the insider received 14,350 and left with 92,252 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, REPL now has a Market Capitalization of 762466816 and an Enterprise Value of 369292768.
Stock Price History:
Over the past 52 weeks, REPL has reached a high of $17.14, while it has fallen to a 52-week low of $4.92. The 50-Day Moving Average of the stock is 8.27%, while the 200-Day Moving Average is calculated to be 33.07%.
Shares Statistics:
It appears that REPL traded 700.19K shares on average per day over the past three months and 998050 shares per day over the past ten days. A total of 61.42M shares are outstanding, with a floating share count of 52.46M. Insiders hold about 23.22% of the company’s shares, while institutions hold 87.94% stake in the company. Shares short for REPL as of 1726185600 were 4859545 with a Short Ratio of 6.94, compared to 1723680000 on 6058822. Therefore, it implies a Short% of Shares Outstanding of 4859545 and a Short% of Float of 10.31.
